NASDAQ : CDXS
Codexis, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 1.19 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 130.31M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 118.16M |
| Enterprise Value | 135.83M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 109.51M |
| Shares Outstanding | 109.51M |
| Shares Change (YoY) | +12.88% |
| Shares Change (QoQ) | +0.31% |
| Owned by Insiders (%) | 6.41% |
| Owned by Institutions (%) | 48.81% |
| Float | 82.30M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.65 |
| Forward PS | 1.54 |
| PB Ratio | 3.30 |
| P/TBV Ratio | 4.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.06 |
| Quick Ratio | 2.83 |
| Debt / Equity | 2.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.68 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -69.36% |
| Return on Assets (ROA) | -11.74% |
| Return on Invested Capital (ROIC) | -13.17% |
| Return on Capital Employed (ROCE) | -25.12% |
| Weighted Average Cost of Capital (WACC) | 13.15% |
| Revenue Per Employee | $532,048 |
| Profits Per Employee | -$210,432 |
| Employee Count | 146 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 33.17 |
Taxes
| Measure | Value |
|---|
| Income Tax | 72,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.39 |
| 52-Week Price Change | -53.80% |
| 50-Day Moving Average | 1.39 |
| 200-Day Moving Average | 1.81 |
| Relative Strength Index (RSI) | 32.02 |
| Average Volume (20 Days) | 853,760 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.95M |
| Short Previous Month | 4.84M |
| Short % of Shares Out | 4.52% |
| Short % of Float | 6.02% |
| Short Ratio (days to cover) | 5.67 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 77.68M |
| Gross Profit | 18.85M |
| Operating Income | -24.26M |
| Pretax Income | -30.65M |
| Net Income | -30.72M |
| EBITDA | -19.05M |
| EBIT | -24.26M |
| Loss Per Share | -$0.34 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 54.92M |
| Total Debt | 72.59M |
| Net Cash | -17.67M |
| Net Cash Per Share | -$0.16 |
| Equity (Book Value) | 32.96M |
| Book Value Per Share | 0.36 |
| Working Capital | 48.41M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -10.40M |
| Capital Expenditures | -1.78M |
| Depreciation & Amortization | 5.21M |
| Net Borrowing | n/a |
| Free Cash Flow | -12.18M |
| FCF Per Share | -$0.11 |
Margins
| Measure | Value |
|---|
| Gross Margin | 24.27% |
| Operating Margin | -31.23% |
| Pretax Margin | -39.46% |
| Profit Margin | -39.55% |
| EBITDA Margin | -24.52% |
| EBIT Margin | -31.23% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -12.88% |
| Shareholder Yield | -12.88% |
| Earnings Yield | -31.41% |
| FCF Yield | -9.51% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $6.14 |
| Price Target Difference | 469.32% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 16.94% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -5.51 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |